Paul V Licciardi
Overview
Explore the profile of Paul V Licciardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
1612
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tuckerman J, Anderson J, Alafaci A, Licciardi P, Steer A, Barr I, et al.
Arch Dis Child
. 2025 Mar;
PMID: 40089271
No abstract available.
2.
Quang C, Anderson J, Russell F, Reyburn R, Ratu T, Tuivaga E, et al.
Nat Commun
. 2025 Mar;
16(1):2130.
PMID: 40032823
The WHO has given a permissive recommendation for an off-label one-dose human papillomavirus (HPV) vaccine schedule to prevent cervical cancer, based on evidence of comparable protection to two or three...
3.
Mazarakis N, Toh Z, Nguyen J, Higgins R, Rudge J, Whittle B, et al.
Antibodies (Basel)
. 2025 Feb;
14(1).
PMID: 39982228
Serological surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies is important to monitor population COVID-19 immunity. Dried blood spots (DBS) are a valuable method for serosurveys, particularly in...
4.
Mazarakis N, Toh Z, Neal E, Bright K, Luu S, Quah L, et al.
J Infect
. 2025 Feb;
90(3):106447.
PMID: 39978439
Objectives: We conducted a randomised controlled trial (RCT) to compare immunogenicity, reactogenicity and safety one month after a fourth COVID-19 mRNA or protein vaccine dose. Methods: This RCT recruited healthy...
5.
Osei I, Schmidt-Chanasit J, Licciardi P, Secka O, DAlessandro U, Salaudeen R, et al.
Vaccine
. 2025 Jan;
47:126712.
PMID: 39798436
Introduction: Because booster doses of pneumococcal conjugate vaccine (PCV) may be given at a similar time to yellow fever vaccine (YF), it is important to assess the immune response to...
6.
Osowicki J, Frost H, Azzopardi K, Whitcombe A, McGregor R, Carlton L, et al.
Nat Commun
. 2024 Dec;
15(1):10506.
PMID: 39627204
Knowledge gaps regarding human immunity to Streptococcus pyogenes have impeded vaccine development. To address these gaps and evaluate vaccine candidates, we established a human challenge model of S. pyogenes pharyngitis....
7.
Toh Z, Anderson J, Mazarakis N, Quah L, Nguyen J, Higgins R, et al.
Clin Transl Immunology
. 2024 Oct;
13(10):e70008.
PMID: 39364394
Objectives: The immune response in children elicited by SARS-CoV-2 Omicron infection alone or in combination with COVID-19 vaccination (hybrid immunity) is poorly understood. We examined the humoral and cellular immune...
8.
Anderson J, Do L, van Kasteren P, Licciardi P
EBioMedicine
. 2024 Sep;
107:105318.
PMID: 39217853
Severe respiratory syncytial virus (RSV) disease is a significant contributor to the global burden of disease in infants and children. The RSV attachment protein (G) has been shown to be...
9.
Niyomnaitham S, Chokephaibulkit K, Pheerapanyawaranun C, Toh Z, Licciardi P, Satayasanskul A, et al.
J Nutr Health Aging
. 2024 Jul;
28(8):100315.
PMID: 39025017
Objectives: Impact of frailty towards immunogenicity and reactogenicity of BNT162b2 boosters administered via intramuscular or intradermal routes in a Thai geriatric population DESIGN: Prospective, randomized, open-labeled. Setting: Siriraj Hospital, Thailand....
10.
Anderson J, Quah L, Mangano K, Pellicci D, Mazarakis N, Licciardi P
J Immunol Methods
. 2024 Jul;
532:113726.
PMID: 38992764
High dimensional immunophenotyping panels are invaluable resources for performing extensive phenotyping on peripheral blood mononuclear cells (PBMCs). We designed a 38-colour high dimensional phenotyping panel to measure innate (monocytes, dendritic...